Centivax, Inc is a biotech company based in South San Francisco, CA, dedicated to accelerating the world's transition to a post-pathogen humanity. They are currently developing a groundbreaking broad-spectrum vaccine for the prevention of all influenza, which has been recognized with a Gates Foundation Grand Challenge End the Pandemic Threat and featured in the Netflix docuseries "Pandemic: How to Prevent an Outbreak."
With a focus on pre-clinical development in ferrets and pigs, Centivax aims to revolutionize the field of vaccination and contribute to global health by combatting infectious diseases. Stay updated on their progress by following their CEO, Dr. Jacob Glanville, on social media.
Generated from the website